Search Results for: Galera Therapeutics Receives FDA Breakthrough
Articles
March 6, 2018
Galera Therapeutics Receives FDA Breakthrough Therapy Designation March 6, 2018
Galera Therapeutics, Inc. recently announced that the US FDA has granted Breakthrough Therapy designation to lead candidate GC4419, a highly...
